Overview
Preeti Parekh is a Hematologist in Raleigh, North Carolina. Dr. Parekh is rated as an Experienced provider by MediFind in the treatment of Smoldering Multiple Myeloma. Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Gallbladder Disease, and Rosai-Dorfman Disease.
Her clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
4420 Lake Boone Trl, Raleigh, NC 27607
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of North Carolina At Chapel Hill
Sascha Tuchman is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Tuchman is rated as an Elite provider by MediFind in the treatment of Smoldering Multiple Myeloma. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Tuchman is currently accepting new patients.
Duke Adult Blood And Marrow Transplant Clinic
The Division of Cellular Therapy does bone marrow transplants and stem cell transplants for patients with different types of blood cancers. Specifically, I see patients with multiple myeloma or other plasma cell issues like amyloidosis. Many of the cases in my clinic are difficult. So I spend a lot of time talking with my patients, explaining the disease when they come as new patients and talking about the complexity of the disease, because it’s important that they understand what to ask their physicians here at Duke and at home. There’s no standard treatment for myeloma. We have different options – continuation of therapy, immediate transplant or transplant later. I like to explain to patients why I favor a certain treatment approach and why I think it would be the best approach for them. Dr. Gasparetto is rated as a Distinguished provider by MediFind in the treatment of Smoldering Multiple Myeloma. Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Colonoscopy.
Duke Blood Cancer Center
An interest in biological sciences and giving back to the community drove me to medical school, but it has been a desire to advance the field of hematologic malignancies, specifically Multiple Myeloma, that brings me to Duke Health. Cancer is a life-altering diagnosis. With a strong, competent team caring for a patient, there can be many success stories. My goal is to empower my patients to understand their diagnosis and how to manage their disease while providing them with many treatment options along the way. Dr. Costa is rated as an Advanced provider by MediFind in the treatment of Smoldering Multiple Myeloma. Her top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, Smoldering Multiple Myeloma, Hereditary Cerebral Amyloid Angiopathy, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AnemiaDr. Parekh isExperienced. Learn about Anemia.
- AngiomyomaDr. Parekh isExperienced. Learn about Angiomyoma.
- Gallbladder DiseaseDr. Parekh isExperienced. Learn about Gallbladder Disease.
- HistiocytosisDr. Parekh isExperienced. Learn about Histiocytosis.
- Langerhans Cell HistiocytosisDr. Parekh isExperienced. Learn about Langerhans Cell Histiocytosis.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)

